Development of radiosensitizers: a medicinal chemistry perspective.
D000818:Animals; D004583:Electrons; D006571:Heterocyclic Compounds / Q000138:chemical synthesis; D006801:Humans; D000860:Hypoxia / Q000517:prevention & control; D009578:Nitrobenzenes / Q000494:pharmacology; D009593:Nitroimidazoles / Q000494:pharmacology; D011838:Radiation-Sensitizing Agents / Q000138:chemical synthesis* / Q000378:metabolism / Q000633:toxicity; D012995:Solubility; D013329:Structure-Activity Relationship
D006571:Heterocyclic Compounds; D009578:Nitrobenzenes; D009593:Nitroimidazoles; D011838:Radiation-Sensitizing Agents